Compound Physician required
DSIP (Emideltide)
Delta sleep-inducing peptide marketed for sleep — no published human RCT.
What it does
Delta sleep-inducing peptide, marketed for sleep with no published human RCT. Tracked, not recommended.
What the evidence shows
Overall evidence strength: Very low certainty
Who it's for, who should skip
Not available or recommended. Status is prohibited — PCAC voted against inclusion in July 2026. Tracked pending a published human sleep RCT.
Access & cost
Not available through licensed channels. Tracked here, not recommended for acquisition.
Last reviewed 27 August 2026. Regulatory status verified 27 August 2026.